Company Lepu Medical Technology (Beijing) Co., Ltd.
Equities
300003
CNE100000H44
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.36 CNY | +1.13% | +7.89% | -11.14% |
Business Summary
- sale of medical devices and instruments (57.9%): primarily for cardiovascular interventions, cardiac surgery, cardiac rhythm management, anesthesia, intensive care, in vitro diagnostics and general surgery;
- sale of active pharmaceutical ingredients (30.6%): for the manufacturing of pharmaceutical products in the fields of cardiovascular diseases, infectious diseases, oncology, central nervous system disorders, etc.;
- sale of digital health and hospital network management solutions (11.6%).
China accounts for 64.7% of net sales.
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Equipment
46.0
%
| 5,879 | 55.4 % | 3,674 | 46.0 % | -37.50% |
Pharmaceutical
38.1
%
| 3,438 | 32.4 % | 3,044 | 38.1 % | -11.47% |
Medical Services and Health Management
15.8
%
| 1,293 | 12.2 % | 1,262 | 15.8 % | -2.37% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 9,529 | 89.8 % | 7,980 | 100.0 % | -16.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Bin Zhang
CEO | Chief Executive Officer | 48 | 25/04/21 |
Wang Yong
DFI | Director of Finance/CFO | 51 | 28/02/07 |
Zhong Jie Pu
CHM | Chairman | 61 | - |
Jing Jing Li
IRC | Investor Relations Contact | - | - |
Guo Rui Zheng
PRN | Corporate Officer/Principal | 41 | 31/03/21 |
Xiao Yong Wang
SAM | Sales & Marketing | 47 | 31/12/16 |
Wei Na Jiang
SEC | Corporate Secretary | 45 | 13/07/21 |
Zhan Jiang Wei
PRN | Corporate Officer/Principal | 52 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Zhong Jie Pu
CHM | Chairman | 61 | - |
Yang Xu
BRD | Director/Board Member | 57 | 31/12/13 |
Liang Gan
BRD | Director/Board Member | 57 | 21/01/20 |
Qian Chen
BRD | Director/Board Member | 46 | 26/12/13 |
Li Hua Wang
BRD | Director/Board Member | 62 | 20/04/20 |
Fei Pu
BRD | Director/Board Member | 35 | 21/01/20 |
Xing Lin Wang
CHM | Chairman | 62 | 21/01/20 |
Jun Wang
BRD | Director/Board Member | 49 | 21/01/20 |
Qi Hong Wang
BRD | Director/Board Member | 59 | 24/03/21 |
Xin Qu
BRD | Director/Board Member | 61 | 09/03/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,880,610,488 | 1,763,836,391 ( 93.79 %) | 34,794,981 ( 1.850 %) | 93.79 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
280,000,000 | 80.75% | 937,333,600 $ | |
LEPU BIOPHARMA CO., LTD. 14.04% | 225,352,113 | 14.04% | 91,851,268 $ |
18,273,500 | 1.13% | 34,840,621 $ | |
BIOLINERX LTD. 9.43% | 102,437,055 | 9.43% | 7,829,264 $ |
Company contact information
Lepu Medical Technology (Beijing) Co., Ltd.
No. 37 Chaoqian Road Changping District
102200, Beijing
+86 10 8012 0666
http://www.lepumedical.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.14% | 3.68B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- 300003 Stock
- Company Lepu Medical Technology (Beijing) Co., Ltd.